The efficacy and safety of nusinersen within the expanded access program in Russia

The efficacy and safety of nusinersen within the expanded access program in Russia

Introduction. Spinal muscular atrophy is a severe neuromuscular disease characterized by rapid progression of muscle weakness and early death. Pathogenetic therapy with nusinersen can significantly change the course of the disease and enable the patient to acquire new skills. The study of the effica...

Full description

Bibliographic Details
Main Authors: S. B. Artemieva, L. M. Kuzenkova, E. S. Ilyina, Yu. A. Kursakova, L. M. Kolpakchi, E. Yu. Sapego, A. A. Golenko, S. G. Popovich, D. V. Parshin, O. A. Shidlovskaya, Yu. O. Papina, A. V. Monakhova, D. V. Vlodavets
Format: Article
Language:Russian
Published: ABV-press 2020-12-01
Series:Nervno-Myšečnye Bolezni
Subjects:
spinal muscular atrophy
nusinersen
expanded access program
smn1 gene
Online Access:https://nmb.abvpress.ru/jour/article/view/396

Internet

https://nmb.abvpress.ru/jour/article/view/396

Similar Items